CENTRAL PHARMA BIOTECHNICA LIMITED

Active Bedford

Manufacture of fertilizers and nitrogen compounds

3 employees website.com
Life sciences and medical technology Manufacture of fertilizers and nitrogen compoundsOther service activities n.e.c.
C

CENTRAL PHARMA BIOTECHNICA LIMITED

Manufacture of fertilizers and nitrogen compounds

Founded 5 Feb 2021 Active Bedford, United Kingdom 3 employees website.com
Life sciences and medical technology Manufacture of fertilizers and nitrogen compoundsOther service activities n.e.c.
Accounts Submitted 30 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 10 Mar 2026 Next due 24 Mar 2027 9 months remaining
Net assets £-1M £307K 2024 year on year
Total assets £279K £216K 2024 year on year
Total Liabilities £2M £91K 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Central Pharma Caxton Road Elm Farm Ind Estate Bedford MK41 0HT United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CENTRAL PHARMA BIOTECHNICA LIMITED (13182798), an active life sciences and medical technology company based in Bedford, United Kingdom. Incorporated 5 Feb 2021. Manufacture of fertilizers and nitrogen compounds. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2021–2024)

Cash in Bank

£48.80k

Decreased by £56.03k (-53%)

Net Assets

-£1.31M

Decreased by £307.31k (-31%)

Total Liabilities

£1.59M

Increased by £91.06k (+6%)

Turnover

£562.94k

Employees

3

Decreased by 4 (-57%)

Debt Ratio

570%

Increased by 267 (+88%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

3 active
Status
Alwyn Jacobus Nicolaas SmitDirectorBritishEngland655 Feb 2021Active
Karen Yvonne NicholDirectorBritishEngland595 Feb 2021Active
Schalk Willem De BeerDirectorSouth AfricanEngland6428 Mar 2022Active

Shareholders

Shareholders (1)

Central Pharma Contract Holdings Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Notified 5 Feb 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

CENTRAL PHARMA BIOTECHNICA LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Mar 2026Confirmation StatementConfirmation statement made on 10 Mar 2026 with updates
29 Jan 2026Confirmation StatementConfirmation statement made on 4 Jan 2026 with no updates
31 Dec 2025OfficersTermination of Karen Yvonne Nichol as director on 31 Dec 2025
30 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
24 Jul 2025MortgageMortgage Create With Deed With Charge Number Charge Creation Date
10 Mar 2026 Confirmation Statement

Confirmation statement made on 10 Mar 2026 with updates

29 Jan 2026 Confirmation Statement

Confirmation statement made on 4 Jan 2026 with no updates

31 Dec 2025 Officers

Termination of Karen Yvonne Nichol as director on 31 Dec 2025

30 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

24 Jul 2025 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

Recent Activity

Latest Activity

Confirmation statement made on 10 Mar 2026 with updates

2 months ago on 10 Mar 2026

Confirmation statement made on 4 Jan 2026 with no updates

4 months ago on 29 Jan 2026

Termination of Karen Yvonne Nichol as director on 31 Dec 2025

5 months ago on 31 Dec 2025

Annual accounts made up to 31 Dec 2024

8 months ago on 30 Sept 2025

Mortgage Create With Deed With Charge Number Charge Creation Date

10 months ago on 24 Jul 2025